HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 516 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2023. The put-call ratio across all filers is 1.68 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,721,540 | -20.5% | 40,812 | -29.3% | 0.01% | -14.3% |
| Q2 2023 | $5,939,897 | -66.3% | 57,753 | -64.3% | 0.01% | -68.2% |
| Q1 2023 | $17,644,009 | -91.6% | 161,664 | -91.2% | 0.04% | -92.3% |
| Q4 2022 | $210,130,107 | +77.2% | 1,846,486 | -3.6% | 0.57% | +61.8% |
| Q3 2022 | $118,576,000 | -30.5% | 1,915,917 | -8.7% | 0.35% | -34.3% |
| Q2 2022 | $170,703,000 | -22.8% | 2,099,524 | +0.5% | 0.54% | -5.1% |
| Q1 2022 | $221,238,000 | +12.2% | 2,088,726 | +14.1% | 0.57% | +30.7% |
| Q4 2021 | $197,241,000 | -3.9% | 1,830,380 | -2.3% | 0.43% | -6.3% |
| Q3 2021 | $205,154,000 | +20.5% | 1,872,866 | +3.1% | 0.46% | +23.9% |
| Q2 2021 | $170,214,000 | -2.4% | 1,816,601 | -4.1% | 0.37% | -5.8% |
| Q1 2021 | $174,370,000 | +35.5% | 1,894,201 | +7.7% | 0.40% | +26.1% |
| Q4 2020 | $128,711,000 | -19.0% | 1,759,565 | -13.9% | 0.31% | -25.9% |
| Q3 2020 | $158,871,000 | +34.7% | 2,044,543 | -3.7% | 0.42% | +32.9% |
| Q2 2020 | $117,938,000 | +75.4% | 2,123,277 | -6.4% | 0.32% | +49.1% |
| Q1 2020 | $67,224,000 | +0.9% | 2,269,518 | +23.4% | 0.21% | +32.9% |
| Q4 2019 | $66,598,000 | +63.7% | 1,839,718 | +23.2% | 0.16% | +59.4% |
| Q3 2019 | $40,687,000 | – | 1,493,397 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |